Mc Collum Christoferson Group LLC Gt Biopharma, Inc. Transaction History

Mc Collum Christoferson Group LLC

  • $328 Million
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 28, 2023
BUY
$0.22 - $0.55 $3,850 - $9,625
17,500 New
17,500 $5,000

Others Institutions Holding GTBP

# of Institutions
4
Shares Held
564
Call Options Held
0
Put Options Held
0
View Full List

About GT Biopharma, Inc.

GTBP Quotes by TradingView
  • Ticker GTBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,557,700
  • Market Cap $81.7M
  • Description
  • GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate th...
More about GTBP
Track This Portfolio

Track Mc Collum Christoferson Group LLC Portfolio

Follow Mc Collum Christoferson Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Collum Christoferson Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Collum Christoferson Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email